Osaic Holdings’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-290
| Closed | -$1.12K | – | 7714 |
|
|
2024
Q3 | $1.12K | Sell |
290
-20
| -6% | -$55 | ﹤0.01% | 6808 |
|
|
2024
Q2 | $720 | Buy |
310
+156
| +101% | +$403 | ﹤0.01% | 6903 |
|
|
2024
Q1 | $435 | Sell |
154
-4,456
| -97% | -$13.2K | ﹤0.01% | 6846 |
|
|
2023
Q4 | $14.7K | Sell |
4,610
-3,042
| -40% | -$10.4K | ﹤0.01% | 5647 |
|
|
2023
Q3 | $25.2K | Buy |
7,652
+2,746
| +56% | +$8.56K | ﹤0.01% | 5418 |
|
|
2023
Q2 | $16.2K | Buy |
4,906
+375
| +8% | +$1.32K | ﹤0.01% | 5703 |
|
|
2023
Q1 | $15K | Buy |
4,531
+2,017
| +80% | +$7.06K | ﹤0.01% | 5741 |
|
|
2022
Q4 | $8.51K | Buy |
2,514
+1,031
| +70% | +$6.74K | ﹤0.01% | 6033 |
|
|
2022
Q3 | $13K | Sell |
1,483
-1,299
| -47% | -$10.8K | ﹤0.01% | 5891 |
|
|
2022
Q2 | $22K | Sell |
2,782
-566
| -17% | -$4.53K | ﹤0.01% | 5559 |
|
|
2022
Q1 | $32K | Buy |
3,348
+330
| +11% | +$2.95K | ﹤0.01% | 5407 |
|
|
2021
Q4 | $20K | Buy |
3,018
+1,360
| +82% | +$11.4K | ﹤0.01% | 5801 |
|
|
2021
Q3 | $16K | Sell |
1,658
-738
| -31% | -$6.93K | ﹤0.01% | 5930 |
|
|
2021
Q2 | $24K | Buy |
2,396
+1,186
| +98% | +$13.2K | ﹤0.01% | 5551 |
|
|
2021
Q1 | $14K | Hold |
1,210
| – | – | ﹤0.01% | 5717 |
|
|
2020
Q4 | $42K | Sell |
1,210
-1,920
| -61% | -$33.1K | ﹤0.01% | 4678 |
|
|
2020
Q3 | $43K | Sell |
3,130
-7
| -0.2% | -$105 | ﹤0.01% | 4423 |
|
|
2020
Q2 | $52K | Buy |
3,137
+33
| +1% | +$393 | ﹤0.01% | 4161 |
|
|
2020
Q1 | $26K | Buy |
+3,104
| New | +$43.4K | ﹤0.01% | 4464 |
|
Osaic Holdings's LUMO Position: Q4 2024 in Review
Osaic Holdings sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 290 shares — an estimated $1.12K sold.
Osaic Holdings first reported a position in LUMO in Q1 2020 and held it in 19 quarters. The position peaked at $52K in Q2 2020. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.
- Osaic Holdings reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Osaic Holdings sold 290 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $1.12K.
- Osaic Holdings first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
- Osaic Holdings's Lumos Pharma, Inc. Common Stock position peaked at $52K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.
Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.